Bibliographic Source(s)
Academy of Ambulatory Foot and Ankle Surgery. Intermetatarsal neuroma. Philadelphia (PA): Academy of Ambulatory Foot and Ankle Surgery; 2003. 6 p. [15 references] |
Guideline Status
This is the current release of the guideline.
This guideline updates a previous version: Academy of Ambulatory Foot and Ankle Surgery. Intermetatarsal neuroma. Philadelphia (PA): Academy of Ambulatory Foot and Ankle Surgery; 2000. 17 p.
The guideline is reviewed and updated twice a year as needed (in May and October). According to the guideline developer, this guideline has been reviewed and is still considered current as of September 2009. This review involved new literature searches of electronic databases followed by expert committee review of new evidence that has emerged since the original publication date.
UMLS Concepts ( what's this?)
Click to view all guideline(s) indexed with these concepts
ICD9CM:
Diagnostic interview and evaluation, not otherwise specified (89.05); Fracture, cause unspecified (E887); General physical examination (89.7); Neurologic examination (89.13); Reflex sympathetic dystrophy, unspecified (337.20); Reflex sympathetic dystrophy, unspecified (337.21); Tarsal tunnel syndrome (355.5)
MSH:
Adrenal Cortex Hormones; Alcohols; Analgesics; Anesthetics, Local; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bursitis; Electrodiagnosis; Foot Diseases; Fractures, Bone; Immobilization; Magnetic Resonance Imaging; Medical History Taking; Neoplasms; Neuritis; Neurologic Examination; Neuroma; Orthotic Devices; Osteochondritis; Osteotomy; Pain; Palpation; Physical Examination; Physical Therapy Specialty; Positron-Emission Tomography; Reflex Sympathetic Dystrophy; Sclerosing Solutions; Synovitis; Tarsal Tunnel Syndrome; Tomography, Emission-Computed; Tomography, Spiral Computed; Tomography, X-Ray Computed; Vitamin B 12
MTH:
Alcohols; Analgesics; Anti-Inflammatory Agents; Antibiotics; Bursitis; Foot Diseases; Fracture; History taking; Local Anesthetics; Magnetic Resonance Imaging; Neoplasms; Neuritis; Neurologic Examination; Orthotic Devices; Osteochondritis; Pain; Palpation; physical examination; Physical Therapy (Specialty); Positron-Emission Tomography; Reflex Sympathetic Dystrophy; Release of tendon (procedure); roentgenographic; Synovitis; Tomography, Emission-Computed; Tomography, Spiral Computed; Vitamin B 12; X-Ray Computed Tomography
PDQ:
computed tomography; cyanocobalamin; magnetic resonance imaging; pain; tomography, emission computed
SNOMEDCT:
Alcohol (53041004); Analgesic (373265006); Analgesic (53009005); Anti-inflammatory agent (330901000); Anti-inflammatory agent (373283003); Antibiotic (255631004); Arthritis (3723001); Bursitis (84017003); Capsulitis (6858004); Complex regional pain syndrome, type I (128079007); Complex regional pain syndrome, type I (2103002); Computerized axial tomography (77477000); Corticoid preparation (21568003); Corticoid preparation (79440004); Disorder of foot (118932009); Fracture (125605004); Fracture (72704001); History taking (84100007); Immobilization - action (257884004); Local anesthetic (27548001); Local anesthetic (373477003); Magnetic resonance imaging (113091000); Magnetic resonance imaging (312250003); Neoplasm (108369006); Nerve excision (108121002); Neuritis (128192007); Neuritis (84299009); Neurological assessment (225398001); Neurological assessment (84728005); Neuroma (25169009); Neuroma (274089002); Neuroma (443892003); Non-steroidal anti-inflammatory agent (16403005); Non-steroidal anti-inflammatory agent (372665008); Orthotic device (224898003); Osteochondritis (70736000); Osteotomy (150062003); Osteotomy (299713009); Osteotomy (79881004); Osteotomy of metatarsal (8508006); Pain (22253000); Palpation (113011001); Palpation (129434008); Physical assessment (302199004); Physical assessment (5880005); Physical assessment (81375008); Positron emission tomography (363678002); Positron emission tomography (82918005); Release of tendon (122484000); Sclerosing agent (262130007); Sclerosing agent (372654003); Spiral computed tomography scan (116152004); Synovitis (416209007); Tarsal tunnel syndrome (47374004); Vascular insufficiency (86341008); Vitamin B>12< preparation (30010009); Vitamin B>12< preparation (419382002); Vitamin B>12< preparation (81064004)
UMD:
Orthoses (12-837)
Hide...
|
Guideline Category
Diagnosis
Treatment
Clinical Specialty
Podiatry
Intended Users
Podiatrists
Guideline Objective(s)
To provide recommendations for the diagnosis and treatment of intermetatarsal neuroma
Target Population
Patients with intermetatarsal neuroma
Interventions and Practices Considered
Diagnosis
- History, including an evaluation of the chief complaint (nature, location, duration, onset, course, anything that improves or exacerbates symptoms, and any previous treatment) and past medical history (allergies, medications, medical history, surgical history, family history, social history)
- Physical examination, including peripheral vascular, neurological, and orthopedic exams
- Diagnostic procedures, including radiographic examination, laboratory tests, electrodiagnostic studies, current perceptual threshold ultrasound echography, magnetic resonance imaging (MRI), computed tomography (C-T) scan, positron emission tomography (PET) scan
Treatment
- Nonsurgical treatment, such as padding and strapping (taping), orthotics, shoe modifications, oral anti-inflammatory medications (NSAIDs), anti-inflammatory injectables (i.e., corticosteroids), injection of local injectables (i.e., peripheral nerve block), injection of sclerosing agents (i.e., Vitamin B-12, alcohol), analgesics, physical therapy
- Surgical treatment, such as neurectomy (excisional, electrocautery, radiocautery, laser), osteotomy of adjacent metatarsal(s), tendon lengthening/tenotomy/capsulotomy, severing of the intermetatarsal ligament
- Postoperative management, including radiographs, follow-up visits, and weight bearing/immobilization
Major Outcomes Considered
|
Methods Used to Collect/Select the Evidence
Searches of Electronic Databases
Description of Methods Used to Collect/Select the Evidence
The guideline development process began with a thorough MEDLINE search as well as a "call for papers" from the membership of the Academy of Ambulatory Foot and Ankle Surgery at large.
Number of Source Documents
Methods Used to Assess the Quality and Strength of the Evidence
Not stated
Rating Scheme for the Strength of the Evidence
Methods Used to Analyze the Evidence
Review
Description of the Methods Used to Analyze the Evidence
Methods Used to Formulate the Recommendations
Not stated
Rating Scheme for the Strength of the Recommendations
Cost Analysis
A formal cost analysis was not performed and published cost analyses were not reviewed.
Method of Guideline Validation
Internal Peer Review
Description of Method of Guideline Validation
Drafts of the guidelines were reviewed in detail by each member of the Board of Trustees.
|
Major Recommendations
- Diagnosis:
- History: This may include any of the following:
- An evaluation of the chief complaint (including the nature, location, duration, onset, course, anything that improves or exacerbates, and any previous treatment).
- The past medical history (including allergies, medications, medical history, surgical history, family history, and social history).
- Physical examination may include:
- Peripheral vascular
- Neurological (are sensorium in the area intact or altered?)
- Orthopedic
- Palpation may produce:
- A palpable "click" (Mulder's sign)
- Pain/symptoms via lateral pressure
- Digital splaying/juxtaposing
- Palpable interdigital mass
- Pain upon palpation (Direct to the intermetatarsal space)
- Associated deformities
- Diagnostic procedures may include:
- Radiographic examination: X-ray examination may be used to rule out bony pathology (differential diagnosis). X-rays may be weight bearing, partial weight bearing, or non-weight bearing.
- Laboratory tests: Used to rule out inflammatory disease, degenerative joint disease, systemic illness (again, differential diagnosis)
- Electrodiagnostic studies: Possibly useful in ruling out other pathology (i.e. tarsal tunnel syndrome), but not definitive in establishing a diagnosis of intermetatarsal neuroma.
- Current perceptual threshold (neurometer CPT test) may be used as indicated.
- Ultrasound echography
- Magnetic resonance imaging (MRI), computed tomography (C-T) scan, or positron emission tomography (PET) scan
- Differential diagnosis may include:
- Fracture
- Osteochondritis
- Arthritis
- Neoplasms (malignant/benign), (nodules i.e., rheumatoid)
- Capsulitis
- Bursitis
- Tendonitis
- Synovitis
- Neuritis
- Tarsal tunnel syndrome
- Peripheral neuropathy
- Reflex sympathetic dystrophy
- Vascular insufficiency
- Multiple neuromas may be present in the same foot
Nonsurgical Treatment
- Goals of treatment: Conservative (nonsurgical) treatment is primarily geared to relieving symptomatology. In most cases, conservative care should be utilized prior to surgery.
- Types of treatment:
- Padding and strapping (taping)
- Orthotics
- Shoe modifications
- Oral anti-inflammatory medications (NSAIDs)
- Anti-inflammatory injectables (i.e., corticosteroids)
- Injection of local injectables (i.e., peripheral nerve block)
- Injection of sclerosing agents (i.e., Vitamin B-12, alcohol)
- Analgesics
- Physical therapy
Surgical Treatment
- Goals of treatment: The goal of surgical treatment is not only to relieve the symptom(s), but to correct the underlying deformities, and to improve function as well.
- The primary reasons for surgical treatment are:
- Failure of nonsurgical treatment
- Impracticality of nonsurgical treatment
- The patient desires correction of a presenting deformity that is painful and/or causes a degree of loss of function.
- The patient is informed of the procedure(s) to be performed, the treatment alternatives, and the reasonable risks involved, and elects to have surgical intervention.
- Site of surgery: The surgical treatment of intermetatarsal neuroma may be performed in the doctor's office. The hospital or ambulatory surgical center may also be appropriate.
- Anesthesia: Local anesthesia is sufficient, unless there are extenuating circumstances.
- Hemostasis: Absence of bleeding is not required.
- Surgical preparation: Aseptic preparation ("usual" aseptic scrub, prep, draping, and sterile technique).
- Preoperative lab: Necessity based upon the patient's past medical history and current medical status.
- Prophylactic antibiotics: At the discretion of the surgeon (or based upon requirement: i.e., mitral valve prolapse).
- Pathological analysis of surgically removed tissue: recommended.
- Bilateral or multiple surgeries: May be performed at the same surgical session, or in different surgical sessions.
- Second opinion: At the option of the patient or doctor.
Surgical Procedures for the Treatment of Intermetatarsal Neuroma
These may include:
- Neurectomy
- Excisional
- Electrocautery
- Radiocautery
- Laser
- Osteotomy of adjacent metatarsal(s) may be used for intermetatarsal neuroma in the event that the metatarsal is malpositioned or malformed, and that the purpose of the osteotomy is for treatment of both the neuroma and the pathological metatarsal as well.
- Tendon lengthening/tenotomy/capsulotomy may be used for intermetatarsal neuroma in the event that the purpose of these procedures is both for treatment of the neuroma and the soft tissue pathology.
- Severing of the intermetatarsal ligament.
Postoperative Management
- Radiographs: Necessary only if there is accompanying osseous and/or soft tissue surgery.
- Postoperative visits: In the absence of complications, the patient should initially be seen within the first week following the procedure(s). Subsequent visits are determined by the procedures performed and the postoperative course.
- Weight bearing/immobilization: Based upon the procedures performed and upon the individual patient, full, partial, or non-weight bearing may be utilized. A postoperative shoe may be indicated. Generally, a surgical dressing is applied in the immediate postoperative period. This is modified with time and the postoperative course. The return to a normal shoe is based upon the procedure(s) performed and the postoperative course of the individual patient. Casting is usually not necessary.
|
Evidence Supporting the Recommendations
Type of Evidence Supporting the Recommendations
The type of supporting evidence is not specifically stated for each recommendation.
|
Benefits/Harms of Implementing the Guideline Recommendations
Potential Benefits
Treatment may relieve symptomatology and improve function.
Potential Harms
Postoperative Complications
- Numbness
- Edema
- Recurrence
- Pain
- Digital or metatarsophalangeal joint instability
- Hematoma
- Stump neuroma
- Infection
- Painful and/or hypertrophic scar formation
- Reflex sympathetic dystrophy
- Vascular complications
- Gangrene
- Fibrosis (intermetatarsal)
- Tissue necrosis
- Plantar fat pad atrophy
|
Implementation of the Guideline
Description of Implementation Strategy
An implementation strategy was not provided.
|
Institute of Medicine (IOM) National Healthcare Quality Report Categories
IOM Care Need
Getting Better
Living with Illness
IOM Domain
Effectiveness
Patient-centeredness
|
Identifying Information and Availability
Bibliographic Source(s)
Academy of Ambulatory Foot and Ankle Surgery. Intermetatarsal neuroma. Philadelphia (PA): Academy of Ambulatory Foot and Ankle Surgery; 2003. 6 p. [15 references] |
Adaptation
Not applicable: The guideline was not adapted from another source.
Date Released
2000 (revised 2003 Sep; reviewed 2009 Sep)
Guideline Developer(s)
Academy of Ambulatory Foot and Ankle Surgery - Medical Specialty Society
Source(s) of Funding
Academy of Ambulatory Foot and Ankle Surgery (AAFAS)
Guideline Committee
Preferred Practice Guidelines Committee
Composition of Group That Authored the Guideline
The committee consisted of five (5) members who were board certified, had a minimum of ten (10) years of clinical practice experience, and a minimum of five (5) years of teaching experience.
Financial Disclosures/Conflicts of Interest
Guideline Status
This is the current release of the guideline.
This guideline updates a previous version: Academy of Ambulatory Foot and Ankle Surgery. Intermetatarsal neuroma. Philadelphia (PA): Academy of Ambulatory Foot and Ankle Surgery; 2000. 17 p.
The guideline is reviewed and updated twice a year as needed (in May and October). According to the guideline developer, this guideline has been reviewed and is still considered current as of September 2009. This review involved new literature searches of electronic databases followed by expert committee review of new evidence that has emerged since the original publication date.
Guideline Availability
Electronic copies: Not available at this time.
Print copies: Available from the Academy of Ambulatory Foot and Ankle Surgery (AAFAS) (formerly the Academy of Ambulatory Foot Surgery), 1601 Walnut Street, Suite 1005, Philadelphia, PA 19102; Web site, www.academy-afs.org .
Availability of Companion Documents
NGC Status
This summary was completed by ECRI on October 12, 2000. The information was verified by the guideline developer as of December 8, 2000. This summary was updated by ECRI on December 19, 2003. The information was verified by the guideline developer on December 29, 2003. This summary was updated on May 3, 2005 following the withdrawal of Bextra (valdecoxib) from the market and the release of heightened warnings for Celebrex (celecoxib) and other nonselective nonsteroidal anti-inflammatory drugs (NSAIDs). This summary was updated by ECRI on June 16, 2005, following the U.S. Food and Drug Administration advisory on COX-2 selective and non-selective non-steroidal anti-inflammatory drugs (NSAIDs).
Copyright Statement
This NGC summary is based on the original guideline, which is copyrighted by the guideline developer.
|
NGC Disclaimer
The National Guideline Clearinghouseâ„¢ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site. Read full disclaimer...The National Guideline Clearinghouseâ„¢ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.
All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.
Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion-criteria.aspx.
NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.
Readers with questions regarding guideline content are directed to contact the guideline developer. Hide...
|